Pillstats
Rx only · Tablet · Oral

Quinapril

Quinapril Hydrochloride

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US23 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)35208
US makers7 labelers
Packages29
DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown9SUPPLYING
Cipla USA Inc.unknown8SUPPLYING
Solco Healthcare US, LLCunknown4SUPPLYING
BluePoint Laboratoriesunknown4SUPPLYING
Bryant Ranch Prepackrepackager3SUPPLYING
Northwind Health Company, LLCunknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown0SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 19, 2023
    SHORTAGEDrug shortage: Quinapril Hydrochloride Tablet (Lupin Pharmaceuticals, Inc.)

    Quinapril Hydrochloride Tablet — reported in shortage by Lupin Pharmaceuticals, Inc.. Therapeutic category: Cardiovascular.

  • Jan 19, 2023
    SHORTAGEDrug shortage: Quinapril Hydrochloride Tablet (Solco Healthcare US, LLC)

    Quinapril Hydrochloride Tablet — reported in shortage by Solco Healthcare US, LLC. Therapeutic category: Cardiovascular.

  • Dec 7, 2022
    RECALLRecall (Class II): Quinapril Tablets USP, 40 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 2120…

    CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed by major distribution chains nationwide.

  • Dec 7, 2022
    RECALLRecall (Class II): Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 2120…

    CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed by major distribution chains nationwide.

  • Dec 7, 2015
    RECALLRecall (Class III): Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09

    Failed Impurities/Degradation Specifications; Impurity A — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide

  • Sep 17, 2013
    RECALLRecall (Class II): Quinapril Tablets USP, 5 mg, 90 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21…

    Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was found to be above the specification limit at 36 month test interval — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide and Puerto Rico

  • Sep 17, 2013
    RECALLRecall (Class II): Quinapril Tablets USP, 10 mg, 90 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 2…

    Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was found to be above the specification limit at 36 month test interval — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide and Puerto Rico